Deborah Palestrant, Ph.D.

Partner & Executive Chair, 4:59 Initiative, 5AM Ventures

Deborah Palestrant, Ph.D., MBA joined 5AM Ventures in 2018 and is a partner and executive chair of 4:59 Initiative. She has over 20 years of life sciences industry experience including drug discovery, company creation, operations, business development and strategy. Deborah serves on the board of directors of Latigo Biotherapeutics, Nido Biosciences and Nvelop Therapeutics. She also serves on the board of directors and as Treasurer of the New England Venture Capital Association and is a member of the Boston Board of Managers at Life Science Cares. Previously, Deborah was vice president of corporate development and strategy at Relay Therapeutics and senior director of business development and strategy at Editas Medicine. She holds a Ph.D. in biochemistry and molecular biophysics from Columbia University, an MBA from Northeastern University, and was Damon Runyon Cancer Research Foundation Postdoctoral Fellow at The Scripps Research Institute.